Status:
COMPLETED
Metabolic Monitoring During Therapeutic Hypothermia (Cooling) for Hypoxic Ischaemic Encephalopathy
Lead Sponsor:
Kathryn Beardsall
Conditions:
Hypoxic-Ischemic Encephalopathy
Eligibility:
All Genders
Up to 2 years
Phase:
NA
Brief Summary
This study aims to determine if CGM can be safely used in these babies, and to use this alongside innovative methods to measure alternative fuels to optimise care of these vulnerable babies.
Detailed Description
In the UK approximately 1200 babies per year undergo 'cooling' for the treatment of 'birth asphyxia' or hypoxic ischaemic encephalopathy (HIE). HIE not only impacts on brain metabolism but disturbs th...
Eligibility Criteria
Inclusion
- Hypoxic ischaemic encephalopathy Informed parental consent
Exclusion
- Known significant congenital malformation
Key Trial Info
Start Date :
May 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT06932354
Start Date
May 10 2019
End Date
December 31 2024
Last Update
April 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cambridge University Addenbrookes Hospital Trust
Cambridge, cambridge, United Kingdom, CB2 0QQ